The New England journal of medicine, 2023-06, Vol.388 (25), p.2338-2348, Article 2338
- Bolaños-Meade, Javier
- Hamadani, Mehdi
- Wu, Juan
- Al Malki, Monzr M.
- Martens, Michael J.
- Runaas, Lyndsey
- Elmariah, Hany
- Rezvani, Andrew R.
- Gooptu, Mahasweta
- Larkin, Karilyn T.
- Shaffer, Brian C.
- El Jurdi, Najla
- Loren, Alison W.
- Solh, Melhem
- Hall, Aric C.
- Alousi, Amin M.
- Jamy, Omer H.
- Perales, Miguel-Angel
- Yao, Janny M.
- Applegate, Kristy
- Bhatt, Ami S.
- Kean, Leslie S.
- Efebera, Yvonne A.
- Reshef, Ran
- Clark, William
- DiFronzo, Nancy L.
- Leifer, Eric
- Horowitz, Mary M.
- Jones, Richard J.
- Holtan, Shernan G.
2023
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Bolaños-Meade, Javier
- Hamadani, Mehdi
- Wu, Juan
- Al Malki, Monzr M.
- Martens, Michael J.
- Runaas, Lyndsey
- Elmariah, Hany
- Rezvani, Andrew R.
- Gooptu, Mahasweta
- Larkin, Karilyn T.
- Shaffer, Brian C.
- El Jurdi, Najla
- Loren, Alison W.
- Solh, Melhem
- Hall, Aric C.
- Alousi, Amin M.
- Jamy, Omer H.
- Perales, Miguel-Angel
- Yao, Janny M.
- Applegate, Kristy
- Bhatt, Ami S.
- Kean, Leslie S.
- Efebera, Yvonne A.
- Reshef, Ran
- Clark, William
- DiFronzo, Nancy L.
- Leifer, Eric
- Horowitz, Mary M.
- Jones, Richard J.
- Holtan, Shernan G.
- Titel
- Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
- Ist Teil von
- The New England journal of medicine, 2023-06, Vol.388 (25), p.2338-2348, Article 2338
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2023
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- In this trial, 1-year GVHD-free, relapse-free survival after stem-cell transplantation was 52.7% in the cyclophosphamide–tacrolimus–mycophenolate mofetil group and 34.9% in the tacrolimus–methotrexate group.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793, 1533-4406eISSN: 1533-4406DOI: 10.1056/NEJMoa2215943Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10575613
- Format
- –
- Schlagworte
- Adult, Allografts, Antineoplastic Combined Chemotherapy Protocols - therapeutic use, Bone marrow, Bone Marrow Transplantation, Bronchiolitis Obliterans Syndrome - etiology, Bronchiolitis Obliterans Syndrome - prevention & control, Calcineurin inhibitors, Confidence intervals, Cyclophosphamide, Cyclophosphamide - administration & dosage, Death, Disease prevention, Drb1 protein, Graft versus host disease, Graft vs Host Disease - etiology, Graft vs Host Disease - prevention & control, Graft-versus-host reaction, Hematologic Neoplasms - surgery, Hematology, Hematopoietic Stem Cell Transplantation - adverse effects, Hematopoietic Stem Cell Transplantation - methods, Hematopoietic stem cells, Histocompatibility antigen HLA, Humans, Hypothesis testing, Immunosuppression, Leukemia, Lymphoma, Methotrexate, Methotrexate - administration & dosage, Mycophenolate mofetil, Mycophenolic acid, Mycophenolic Acid - administration & dosage, Neoplasm Recurrence, Local - drug therapy, Oncology, Prophylaxis, Stem cell transplantation, Tacrolimus, Tacrolimus - administration & dosage, Transplants & implants, Treatments in Oncology, Unrelated Donors